ARCHIVES

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Barnett Kramer Retires From NIH

January 7, 2011

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

NCI Phone Number Listings Completed

September 21, 1979